Skip to main content
. 2022 Sep 16;82(12):1237–1249. doi: 10.1007/s40265-022-01757-5

Fig. 2.

Fig. 2

Key clinical trials in the management of cryptococcal meningitis. AmB amphotericin B, 5FC flucytosine, CM cryptococcal meningitis, CSF cerebrospinal fluid, 14d 14 days